Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter encodes the cell cycle regulator p16INK4a which is an important target of Epstein-Barr virus (EBV).”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [16]
In the citing paper
“Repression of CDKN2A was reported to be a prerequisite to support cell proliferation long-term as shown in lymphoblastoid B cell lines infected with an EBV derivative with a conditional EBNA3C allele [16].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [16]
In the citing paper
“A single infection experiment with primary B cells from an individual with a genetic lesion that prevents expression of functional p16INK4a is the only direct evidence supporting this claim in a physiological context [16].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [16]
In the citing paper
“Our findings confirmed a previous report [16] documenting that p16INK4a is an important target of the viral EBNA3C repressor protein and the only barrier to EBV-induced B cell proliferation.”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [16]
In the citing paper
“Our results after CDKN2A knockout shown in Fig 4 corroborated this notion with primary B cells from six donors recapitulating a situation with B cells from a rare p16INK4a deficient individual [16].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [16]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“It is well established that polycomb-mediated gene repression is often a precursor to promoter DNA methylation (reviewed in [7,56]), so it is reasonable to hypothesize that the B cells reprogrammed in vivo by EBV will be particularly prone to aberrant DNA methylation at the CDKN2A and BCL2L11 loci during tumorigenesis.”
BackgroundCellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 2×
“Both genes are progressively up-regulated with tissue aging and they probably contribute to the process of aging in vivo by reducing reservoirs of self-renewing stem cells [3,4].”
BackgroundEZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 6×
“mutant or deregulated oncogenes (this is sometimes called ‘oncogenic stress’) [3,4].”
BackgroundMethodInfluentialShieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 6×
“By binding CDKs and blocking Rb phosphorylation, increased p16 expression leads to a G1 cell cycle arrest (reviewed in [1,2]).”
BackgroundMethodInfluentialThe p53 network: cellular and systemic DNA damage responses in aging and Cancer
Reinhardt, H. C., & Schumacher, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2011.12.002 · Cited by 458
INK4a/ARF: A multifunctional tumor suppressor locus
Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442 · cited 2×
“The second target gene, INK4a, encodes the cyclin dependent kinase inhibitor p16 that prevents the phosphorylation of the tumour suppressor Rb and the resulting hypophosphorylated Rb blocks entry of cells into S phase of the cell cycle ([25,37]; reviewed in [1,2]).”
BackgroundINK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220 · cited 4×
“In the LCL 3CHT expression of both p16 and p14/p16 was induced by removal of 4HT and the non-functional p16/X fusion, although difficult to detect, appeared as a polypeptide doublet (Figure 1D and also [35]).”
BackgroundInfluential
Research works printed but not linked: 54
- AP Bracken, 2009, Polycomb group proteins: navigators of lineage pathways led astray in cancer, Nat Rev Cancer, 9, 773, 10.1038/nrc2736 · DOI · Paper page
- JA Simon, 2009, Mechanisms of polycomb gene silencing: knowns and unknowns, Nat Rev Mol Cell Biol, 10, 697, 10.1038/nrm2763 · DOI · Paper page
- LS Young, 2004, Epstein-Barr virus: 40 years on, Nat Rev Cancer, 4, 757, 10.1038/nrc1452 · DOI · Paper page
- GW Bornkamm, 2001, Molecular virology of Epstein-Barr virus, Philos Trans R Soc Lond B Biol Sci, 356, 437, 10.1098/rstb.2000.0781 · DOI
- R Touitou, 2001, Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C, J Virol, 75, 7749, 10.1128/JVI.75.16.7749-7755.2001 · DOI
- M Hickabottom, 2002, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP), J Biol Chem, 277, 47197, 10.1074/jbc.M208116200 · DOI
- GA Parker, 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7, Oncogene, 13, 2541
- JS Knight, 2005, SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen, Mol Cell Biol, 25, 1749, 10.1128/MCB.25.5.1749-1763.2005 · DOI
- JS Knight, 2005, Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase, Proc Natl Acad Sci U S A, 102, 18562, 10.1073/pnas.0503886102 · DOI · Paper page
- JS Knight, 2004, Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity, J Virol, 78, 1981, 10.1128/JVI.78.4.1981-1991.2004 · DOI
- BG Bajaj, 2008, Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein, J Virol, 82, 4082, 10.1128/JVI.02500-07 · DOI
- A Saha, 2009, Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2, J Virol, 83, 4652, 10.1128/JVI.02408-08 · DOI
- F Yi, 2009, Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities, Virology, 388, 236, 10.1016/j.virol.2009.03.027 · DOI
- T Choudhuri, 2007, The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block, J Virol, 81, 6718, 10.1128/JVI.00053-07 · DOI
- A Saha, 2011, EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5, J Virol, 85, 2079, 10.1128/JVI.02279-10 · DOI
- A Saha, 2012, E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells, PLoS Pathogens, 8, e1002573, 10.1371/journal.ppat.1002573 · DOI
- E Anderton, 2008, Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma, Oncogene, 27, 421, 10.1038/sj.onc.1210668 · DOI · Paper page
- K Paschos, 2009, Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim, PLoS Pathogens, 5, e1000492, 10.1371/journal.ppat.1000492 · DOI · Paper page
- L Skalska, 2010, Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP, PLoS Pathogens, 6, e1000951, 10.1371/journal.ppat.1000951 · DOI · Paper page
- RE White, 2010, Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification, PloS One, 5, e13979, 10.1371/journal.pone.0013979 · DOI
- RE White, 2012, EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors, The Journal of Clinical Investigation, 122, 1487, 10.1172/JCI58092 · DOI · Paper page
- K Paschos, 2012, BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV, Nucleic Acids Research, 40, 7233, 10.1093/nar/gks391 · DOI
- MJ McClellan, 2012, Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements, J Virol, 86, 5165, 10.1128/JVI.07161-11 · doi:10.1128/jvi.07161-11
- ML Hertle, 2009, Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes, PLoS Pathogens, 5, e1000506, 10.1371/journal.ppat.1000506 · DOI
- B Zhao, 2011, Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines, Proc Nat Acad Sci USA, 108, 337, 10.1073/pnas.1017419108 · DOI
- S Maruo, 2011, Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression, Proc Nat Acad Sci USA, 108, 1919, 10.1073/pnas.1019599108 · DOI
- BE Bernstein, 2006, A bivalent chromatin structure marks key developmental genes in embryonic stem cells, Cell, 125, 315, 10.1016/j.cell.2006.02.041 · DOI · Paper page
- NA Gruis, 1995, Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds, Nature Genetics, 10, 351, 10.1038/ng0795-351 · DOI · Paper page
- MJ Hayes, 2004, p16(INK4A)-independence of Epstein-Barr virus-induced cell proliferation and virus latency, The Journal of General Virology, 85, 1381, 10.1099/vir.0.79831-0 · DOI
- S Maruo, 2006, Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells, Proc Natl Acad Sci U S A, 103, 19500, 10.1073/pnas.0604919104 · DOI · Paper page
- M Muramatsu, 2000, Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme, Cell, 102, 553, 10.1016/S0092-8674(00)00078-7 · DOI · Paper page
- AP Bracken, 2004, E2F target genes: unraveling the biology, Trends in Biochemical Sciences, 29, 409, 10.1016/j.tibs.2004.06.006 · DOI · Paper page
- Q Cai, 2011, Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis, PLoS Pathogens, 7, e1002418, 10.1371/journal.ppat.1002418 · DOI
- J O'Nions, 2006, Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53, J Virol, 80, 12408, 10.1128/JVI.01363-06 · DOI
- MJ Allday, 1994, Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells, J Virol, 68, 3491, 10.1128/JVI.68.6.3491-3498.1994 · DOI
- E Heath, 2012, Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology, PLoS Pathogens, 8, e1002697, 10.1371/journal.ppat.1002697 · DOI
- MJ Allday, 1989, Epstein-Barr virus latent gene expression during the initiation of B cell immortalization, The Journal of General Virology, 70, 1755, 10.1099/0022-1317-70-7-1755 · DOI
- AJ Sinclair, 1994, EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus, The EMBO Journal, 13, 3321, 10.1002/j.1460-2075.1994.tb06634.x · DOI · Paper page
- LC Spender, 1999, Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus, J Virol, 73, 4678, 10.1128/JVI.73.6.4678-4688.1999 · DOI
- PA Nikitin, 2010, An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells, Cell Host & Microbe, 8, 510, 10.1016/j.chom.2010.11.004 · DOI · Paper page
- A Strasser, 2005, The role of BH3-only proteins in the immune system, Nat Rev Immunol, 5, 189, 10.1038/nri1568 · DOI · Paper page
- E Kashuba, 2003, EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells, International Journal of Cancer, 105, 644, 10.1002/ijc.11124 · DOI
- DA Thorley-Lawson, 2001, Epstein-Barr virus: exploiting the immune system, Nat Rev Immunol, 1, 75, 10.1038/35095584 · DOI · Paper page
- U Klangby, 1998, p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma, Blood, 91, 1680, 10.1182/blood.V91.5.1680 · DOI
- E Nagy, 2005, Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines, Anticancer Research, 25, 2153
- JA Richter-Larrea, 2010, Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma, Blood, 116, 2531, 10.1182/blood-2010-02-268003 · DOI · Paper page
- J O'Nions, 2003, Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2, Oncogene, 22, 7181, 10.1038/sj.onc.1206838 · DOI
- HJ Delecluse, 1998, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells, Proc Natl Acad Sci U S A, 95, 8245, 10.1073/pnas.95.14.8245 · DOI · Paper page
- F Shaku, 2005, Development of a monoclonal antibody against Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) that can detect EBNA-LP expressed in P3HR1 cells, Microbiology and Immunology, 49, 477, 10.1111/j.1348-0421.2005.tb03743.x · doi:10.1111/j.1348-0421.2005.tb03743.x
- SK Kia, 2008, SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus, Mol Cell Biol, 28, 3457, 10.1128/MCB.02019-07 · DOI · Paper page
- E Turro, 2010, MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays, Nucleic Acids Research, 38, e4, 10.1093/nar/gkp853 · DOI
- T Yates, 2008, X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis, Nucleic Acids Research, 36, D780, 10.1093/nar/gkm779 · DOI
- MJ Okoniewski, 2007, An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data, Genome Biology, 8, R79, 10.1186/gb-2007-8-5-r79 · doi:10.1186/gb-2007-8-5-r79
- C Eisenhart, 1947, The assumptions underlying the analysis of variance, Biometrics, 3, 1, 10.2307/3001534 · DOI · Paper page
Cited by
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Epstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K. M., Kieff, E., & Zhao, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616697113 · Cited by 88
Akidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
Metadata
- Authors
- Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e1003187
- ISSN
- 1553-7374
- Cited by
- 77
- References
- 13
- Language
- en
- Update notices
- correction (2013-03-05)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines. https://app.cochat.ai/papers/10.1371/journal.ppat.1003187
- The paper
- Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J. (2013). Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1003187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.